CompoAtlas

K-C, TCM Concentrate, Chinese Herbal Supplement

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Plantago asiatica

Source : Graine(s)

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 182 mg

26 mgNot calculated
Saposhnikovia divaricata

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 266 mg

38 mgNot calculated
Wolfiporia extensa

Source : Sclerotium

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 266 mg

38 mgNot calculated
Chaenomeles speciosa

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 238 mg

34 mgNot calculated
Morus alba

Source : Écorce de racine

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 238 mg

34 mgNot calculated
Astragalus membranaceus

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 210 mg

30 mgNot calculated
Coix lacryma-jobi var. ma-yuen

Source : Graine(s)

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 182 mg

26 mgNot calculated
Atractylodes macrocephala

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 182 mg

26 mgNot calculated
Magnolia officinalis

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 182 mg

26 mgNot calculated
Paeonia lactiflora

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 182 mg

26 mgNot calculated
Polyporus umbellatus

Source : Sclerotium

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 182 mg

26 mgNot calculated
Cinnamomum aromaticum

Source : Brindille(s)

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 147 mg

21 mgNot calculated
Citrus reticulata

Source : Fruit pericarp

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 147 mg

21 mgNot calculated
Typhonium flagelliforme

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 147 mg

21 mgNot calculated
Glycyrrhiza uralensis

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 91 mg

13 mgNot calculated
Zingiber officinale

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 7:1

Dry plant equivalent : 147 mg

21 mgNot calculated

Non-medicinal ingredients

Gélatine, Dioxyde de silicium, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Combination of Traditional Chinese Medicine ingredients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Nature's Sunshine Products of Canada Ltd.
NPN or DIN-HM
80095754
Status
Active licence
Licence date
25 November 2019
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Traditionnelle

Source

Official Health Canada record, licence 80095754

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    Sources cited by Health Canada (1)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    Sources cited by Health Canada (2)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

    Health Canada monograph dated 29 November 2024

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “K-C, TCM Concentrate, Chinese Herbal Supplement (Nature's Sunshine Products of Canada Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80095754-k-c-tcm-concentrate-chinese-herbal-supplement, updated 25 November 2019.

Enter to analyse, Shift+Enter for a new line